T cell activation in rheumatoid synovium is B cell dependent

Journal of Immunology

Volumn 167, Issue 8, 2001, Pages 4710-4718

  Takemura, S ^a   Klimiuk, P A ^a   Braun, A ^a   Goronzy, J J ^a   Weyand, C M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 1BETA; RITUXIMAB; RNA; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CHIMERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; GERMINAL CENTER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCID MOUSE; SYNOVIUM; T LYMPHOCYTE ACTIVATION;

EID: 0035888030     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.8.4710     Document Type: Article

References (54)

1. Rheumatoid arthritis
2. Extra-articular rheumatoid arthritis: Prevalence and mortality
3. Pathology of rheumatoid arthritis and associated disorders
4. Pathogenesis of rheumatoid arthritis
5. Targeting the T cell receptor in rheumatoid arthritis
6. + T cell differentiation and effector function: Implications for autoimmunity
7. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis
8. Germinal centers
9. Life and death in germinal centers
10. Lymphoid neo-organogenesis: Lymphotoxin's role in inflammation and development
11. Chemokines and cell migration in secondary lymphoid organs
12. + T cells in the formation of germinal centers in rheumatoid synovitis
13. The changing preference of T and B cells for partners as T-dependent antibody responses develop
14. Development and maturation of secondary lymphoid tissues
15. In situ studies of the germinal center reaction
16. B cell memory and the long-lived plasma cell
17. Control of the immune response at the level of antigen-presenting cells: A comparison of the function of dendritic cells and B lymphocytes
18. New roles for rheumatoid factor
19. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
20. Production of cytokines and metalloproteinases in rheumatoid synovitis is T cell dependent
21. + T cells in rheumatoid arthritis
22. Perturbation of the T cell repertoire in rheumatoid arthritis
23. Tissue cytokine patterns distinguish variants of rheumatoid synovitis
24. T cell receptor repertoire in rheumatoid arthritis
25. Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells
26. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice
27. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity
28. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: Analysis of a new "speed congenic" stock of NOD.1g μ null mice
29. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice
30. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice
31. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus
32. Rheumatologic disorders due to immune complexes
33. Rheumatoid arthritis, 1970-1972
34. The biology and detection of immune complexes
35. Activation of the complement and properdin systems in rheumatoid arthritis
36. Immune complexes and induced release of lysosomal enzymes from mononuclear phagocytes in the pathogenesis of rheumatoid arthritis
37. Antigendriven clonal proliferation of B cells within the target tissue of an autoimmune disease: The salivary glands of patients with Sjogren's syndrome
38. Lymphoid neogenesis in rheumatoid synovitis
39. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins
40. T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis
41. Selection of T cells reactive against autologous B lymphoblastoid cells during chronic rheumatoid arthritis
42. Infrequent detection of cytomegalovirus and Epstein-Barr virus DNA in synovial membrane of patients with rheumatoid arthritis
43. EBV gene expression not altered in rheumatoid synovia despite the presence of EBV antigen-specific T cell clones
44. Lack of evidence for an involvement of Epstein-Barr virus infection of synovial membranes in the pathogenesis of rheumatoid arthritis
45. Antigen-presenting cells in rheumatoid arthritis
46. Differentiated dendritic cells expressing nuclear Re1B are predominantly located in rheumatoid synovial tissue perivascular mononuclear cell aggregates
47. Antigen-presenting capacity of rheumatoid synovial fibroblasts
48. Enhanced co-stimulatory ability of synovial fluid accessory cells in rheumatoid arthritis
49. Synovial fluid transforming growth factor β inhibits dendritic cell-T lymphocyte interactions in patients with chronic arthritis
50. Antigen localization regulates immune responses in a dose- and time-dependent fashion: A geographical view of immune reactivity
51. The effect of Rituximab on patients with follicular and mantle-cell lymphoma: Swiss Group for Clinical Cancer Research (SAKK)
52. Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): Analysis of factors associated with response
53. Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma: Results of a phase II trial of Rituximab
54. Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes